ERBB2 and breast carcinoma: To clarify the timing of initiation of AHT and the association with survival for HR-positive and ERBB2 (formerly HER2)-negative early breast cancer without chemotherapy, we conducted a large population-based retrospective study using data from the National Cancer Database (NCDB).